Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Bliss GVS Pharma Ltd Financial Statements & Historical Data

Updated NSE: BLISSGVSBSE: 506197
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 5 October 2026, 8:20 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price665₹ per share
Reported P/E51.3Times
Book value per share113₹ per share
Reported ROCE16.9 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 5 October 2026, 8:20 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap7,063 Cr.
Current Price665
High / Low745/118
Stock P/E51.3
Book Value113
Dividend Yield0.23 %
ROCE16.9 %
ROE11.8 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Bliss GVS Pharma Ltd 7,063 Cr. 665 745/11851.3 1130.23 %16.9 %11.8 % 1.00
Sanofi India Ltd 6,995 Cr. 3,037 4,898/3,00020.4 3592.47 %57.5 %43.0 % 10.0
Entero Healthcare Solutions Ltd 7,315 Cr. 1,681 1,920/94456.7 3880.00 %10.5 %6.94 % 10.0
Morepen Laboratories Ltd 7,327 Cr. 134 135/33.062.4 22.80.15 %8.05 %5.33 % 2.00
IOL Chemicals & Pharmaceuticals Ltd 6,146 Cr. 209 219/67.134.8 61.30.48 %11.3 %8.42 % 2.00
Industry Average17,523.99 Cr1,246.1054.94211.240.39%26.16%16.59%6.06

All Competitor Stocks of Bliss GVS Pharma Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 160212201198184218210198207244218257286
Expenses 135158157170149176181177166201183213209
Operating Profit 24544428344130214143354476
OPM % 15%26%22%14%19%19%14%11%20%18%16%17%27%
Other Income 5135-24451512358161110
Interest 1122241253121
Depreciation 66777788888910
Profit before tax 225940-4303636236341414575
Tax % 34%27%27%24%26%28%29%29%30%30%39%18%32%
Net Profit 144329-5222626174429253751
EPS in Rs 1.414.052.64-0.871.972.312.261.474.082.582.203.364.72

Last Updated: September 30, 2026, 12:08 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 12:02 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 3454075477988158996895777477527708109271,005
Expenses 273304391596618739566471629634620683760806
Operating Profit 71103156203197160123107118117151127168199
OPM % 21%25%29%25%24%18%18%18%16%16%20%16%18%20%
Other Income 28202412-8352620-4218-0366745
Interest 181619202348651078127
Depreciation 111113202191317171926293335
Profit before tax 719614817514518212910454106117126190202
Tax % 42%36%32%36%39%30%26%29%57%28%30%28%29%
Net Profit 416110011389127957423778290135142
EPS in Rs 3.975.818.007.955.7011.999.436.641.456.807.218.0012.2112.86
Dividend Payout % 13%12%6%8%18%8%5%8%34%7%7%6%4%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)48.78%63.93%13.00%-21.24%42.70%-25.20%-22.11%-68.92%234.78%6.49%9.76%50.00%
Change in YoY Net Profit Growth (%)0.00%15.15%-50.93%-34.24%63.94%-67.89%3.09%-46.81%303.70%-228.29%3.26%40.24%

Bliss GVS Pharma Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:3%
3 Years:3%
TTM:5%
Compounded Profit Growth
10 Years:3%
5 Years:-5%
3 Years:44%
TTM:4%
Stock Price CAGR
10 Years:0%
5 Years:1%
3 Years:24%
1 Year:22%
Return on Equity
10 Years:12%
5 Years:8%
3 Years:9%
Last Year:8%

Last Updated: September 5, 2025, 1:05 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: August 31, 2026, 3:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 101010101010101010101111
Reserves 3274024765266367257988088739571,0401,182
Borrowings 1601322251181021261221091021008822
Other Liabilities 166218311206157168147181171145163278
Total Liabilities 6627621,0238609051,0301,0771,1091,1571,2121,3011,492
Fixed Assets 234225305143146242234281379370406459
CWIP 094047022238216
Investments 000000028445
Other Assets 4285277147177127888408037688308711,022
Total Assets 6627621,0238609051,0301,0771,1091,1571,2121,3011,492
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 381132891840476413534103106139
Cash from Investing Activity + -29-50-24948-79-40-45-103-6-83-75-38
Cash from Financing Activity + -42-40-10-7617-6-21-24-25-21-30-89
Net Cash Flow -342330-10-220-293-1011
Free Cash Flow 5101186-72-125563-59753384
CFO/OP 45%101%160%29%-8%69%87%143%67%91%112%108%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow5.00101.00186.00-7.002.00-12.0055.0063.00-59.0075.0033.0084.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 228222201116134187290293192187192198
Inventory Days 7069555055466411011694113111
Days Payable 1761651531005547758286795863
Cash Conversion Cycle 12112610267134186279321221202247246
Working Capital Days 8610584-10135154232264179192207199
ROCE %20%23%31%29%27%26%18%12%14%12%14%12%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 35.06%34.97%34.97%34.90%34.82%35.10%35.29%35.44%35.39%35.36%35.36%35.01%
FIIs 16.31%15.35%14.74%13.24%12.13%13.51%13.18%12.65%13.27%14.54%10.45%8.07%
DIIs 6.61%6.60%6.59%6.58%6.56%6.55%6.55%6.54%5.98%5.78%5.04%9.46%
Public 42.00%43.08%43.71%45.27%46.49%44.84%44.98%45.37%45.36%44.32%49.15%47.45%
No. of Shareholders 43,23440,75845,15744,73752,93749,55849,51746,70744,46143,38044,87446,767
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal S&P BSE Healthcare ETF 669 0.07 0.016692025-04-22 17:25:400%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 8.027.236.831.466.64
Diluted EPS (Rs.) 7.957.116.721.436.49
Cash EPS (Rs.) 11.3610.319.163.908.84
Book Value[Excl.RevalReserv]/Share (Rs.) 99.6895.8088.0881.6480.27
Book Value[Incl.RevalReserv]/Share (Rs.) 99.6895.8088.0881.6480.27
Revenue From Operations / Share (Rs.) 76.8573.5772.1672.0955.96
PBDIT / Share (Rs.) 15.4917.1312.9714.4512.30
PBIT / Share (Rs.) 12.6914.6111.1812.7810.63
PBT / Share (Rs.) 11.9211.1610.185.2210.10
Net Profit / Share (Rs.) 8.577.797.372.237.17
NP After MI And SOA / Share (Rs.) 8.007.216.801.456.64
PBDIT Margin (%) 20.1523.2817.9720.0421.98
PBIT Margin (%) 16.5119.8615.4917.7218.99
PBT Margin (%) 15.5115.1714.117.2418.03
Net Profit Margin (%) 11.1410.5910.203.0912.81
NP After MI And SOA Margin (%) 10.419.799.422.0111.86
Return on Networth / Equity (%) 8.027.808.011.838.47
Return on Capital Employeed (%) 11.8414.5112.0815.1312.55
Return On Assets (%) 6.486.216.121.356.36
Long Term Debt / Equity (X) 0.010.030.040.020.04
Total Debt / Equity (X) 0.060.090.110.120.12
Asset Turnover Ratio (%) 0.640.640.530.590.47
Current Ratio (X) 4.815.083.613.333.76
Quick Ratio (X) 4.084.343.082.803.27
Inventory Turnover Ratio (X) 6.633.062.963.712.73
Dividend Payout Ratio (NP) (%) 6.226.907.3234.417.52
Dividend Payout Ratio (CP) (%) 4.615.115.7915.986.01
Earning Retention Ratio (%) 93.7893.1092.6865.5992.48
Cash Earning Retention Ratio (%) 95.3994.8994.2184.0293.99
Interest Coverage Ratio (X) 20.1025.9513.0431.6023.01
Interest Coverage Ratio (Post Tax) (X) 12.1217.038.4021.4014.42
Enterprise Value (Cr.) 1137.761087.33770.70752.99990.81
EV / Net Operating Revenue (X) 1.411.411.031.011.72
EV / EBITDA (X) 6.976.065.705.037.81
MarketCap / Net Operating Revenue (X) 1.531.530.981.071.76
Retention Ratios (%) 93.7793.0992.6765.5892.47
Price / BV (X) 1.181.220.830.971.26
Price / Net Operating Revenue (X) 1.531.530.981.071.76
EarningsYield 0.060.060.090.010.06
Advertisements
Explore Industry-wise Company financial data